# EODHD Limited Factor Diagnostics Review Checkpoint

Date: 2026-06-28

This checkpoint adds a private-output-only limited factor diagnostics review
for the EODHD workflow. It reads the private factor diagnostics dry-run
summary, experiment log, and readiness review, then summarizes only the
allowed diagnostics.

It does not fetch data, call vendor APIs, use credentials, commit private
market data, run a strategy, run a backtest, build a portfolio, simulate
trades, calculate PnL, calculate Sharpe, calculate drawdown, make an
investment recommendation, claim profitability, claim alpha, or claim trading
readiness.

## Private Output

Private JSON limited review:

```text
/Users/rhapsoul/Documents/Codex/private_data/eodhd_first_dry_run/LIMITED_FACTOR_DIAGNOSTICS_REVIEW.json
```

Private Markdown limited review:

```text
/Users/rhapsoul/Documents/Codex/private_data/eodhd_first_dry_run/LIMITED_FACTOR_DIAGNOSTICS_REVIEW.md
```

Both files remain outside the repository and are not git-tracked.

## Review Scope

Allowed diagnostics:

- Factor coverage.
- Factor missingness.
- IC.
- Rank IC.
- Quantile spread.
- Sample split labels when present.

The private output may contain diagnostic values. This repository checkpoint
records only aggregate counts, output paths, and guardrails.

## Aggregate Result

| Field | Result |
| --- | --- |
| Factors reviewed | 2 |
| Split labels | test, train, validation |
| Asset rows | 21320 |
| Benchmark rows | 2132 |
| Symbol coverage | 11 |
| Date range | 2018-01-02 to 2026-06-26 |
| Sensitive-marker hits in private limited-review outputs | 0 |

## Caveats

- Diagnostics are research diagnostics only.
- The selected universe is static and is not point-in-time membership.
- Raw OHLC fields and `adjusted_close` may have different adjustment
  semantics.
- IC, Rank IC, and quantile spreads are not strategy, portfolio, performance,
  alpha, investment, profitability, or trading-readiness evidence.

## Next Safe Checkpoint

Decide whether another metadata-only methodology/data-readiness checkpoint is
needed before any broader research interpretation. Stop before strategy runs,
backtests, portfolio construction, PnL, Sharpe, drawdown, trading metrics,
investment recommendations, profitability claims, alpha claims, or
trading-readiness claims.
